MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about compliance certificate

13 Jan 2022 Evaluate
Jagsonpal Pharmaceuticals has informed that it enclosed compliance certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1751.80
Dr. Reddys Labs. 1235.90
Cipla 1328.10
Lupin 1960.00
Zydus Lifesciences 1123.40
View more..